Compare STKE & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STKE | LNZA |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 77.5M |
| IPO Year | 2021 | 2021 |
| Metric | STKE | LNZA |
|---|---|---|
| Price | $1.31 | $4.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 442.0K | 57.0K |
| Earning Date | 01-28-2027 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 17.00 |
| Revenue | N/A | ★ $55,845,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.26 |
| Revenue Growth | N/A | ★ 12.61 |
| 52 Week Low | $0.85 | $4.30 |
| 52 Week High | $3.95 | $44.00 |
| Indicator | STKE | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 31.57 |
| Support Level | $1.00 | N/A |
| Resistance Level | $1.37 | $6.55 |
| Average True Range (ATR) | 0.14 | 0.39 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 9.02 | 17.77 |
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.